KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Encompass Health (EHC) EPS (Weighted Average and Diluted) (2016 - 2025)

Encompass Health (EHC) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $1.43 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 24.35% year-over-year to $1.43, compared with a TTM value of $5.54 through Dec 2025, up 24.49%, and an annual FY2025 reading of $5.54, up 24.22% over the prior year.
  • EPS (Weighted Average and Diluted) was $1.43 for Q4 2025 at Encompass Health, up from $1.24 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $1.48 in Q1 2025 and bottomed at $0.03 in Q4 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.96, with a median of $0.99 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 96.51% in 2021, then soared 2900.0% in 2022.
  • Year by year, EPS (Weighted Average and Diluted) stood at $0.03 in 2021, then skyrocketed by 2900.0% to $0.9 in 2022, then decreased by 8.89% to $0.82 in 2023, then soared by 40.24% to $1.15 in 2024, then increased by 24.35% to $1.43 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for EHC at $1.43 in Q4 2025, $1.24 in Q3 2025, and $1.39 in Q2 2025.